V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20215187 | 20081355 | 1.79 | 60.05 | Palliative (P) | 2019-07-17 | 2019-07-17 | Trial Unspecified | Y | N | TRIAL | 100960255 |
| 20215188 | 20081356 | 1.78 | null | Neo-adjuvant (N) | 2020-04-26 | 2020-05-15 | Trial Unspecified | 01 | N | TRIAL | 101760136 |
| 20215189 | 20081357 | 1.67 | 93.6 | Palliative (P) | 2019-06-08 | 2019-06-12 | Imatinib 200mg | 02 | N | IMATINIB | 101558632 |
| 20215191 | 20081358 | 1.74 | 71 | Curative (C) | 2016-03-30 | 2016-04-05 | FLUOROURACIL + MITOMYCIN + RT | N | Y | FLUOROURACIL + MITOMYCIN + RT | 100148502 |
| 20215192 | 20081359 | 1.84 | 80.2 | Palliative (P) | 2019-10-29 | 2019-10-29 | Cape+Cisplatin+Trastuzumab Load | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101661841 |
| 20215193 | 20081360 | 1.71 | 70.6 | Palliative (P) | 2016-12-26 | 2016-12-26 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100558627 |
| 20215194 | 20081361 | null | 77.9 | Palliative (P) | 2018-11-25 | 2018-12-11 | LANREOTIDE | N | N | LANREOTIDE | 101774733 |
| 20215195 | 20081362 | 0 | 74.7 | null | 2016-03-03 | 2016-03-03 | LANREOTIDE | N | null | LANREOTIDE | 100590293 |
| 20215196 | 20081363 | 0 | 77 | Palliative (P) | 2018-03-04 | 2018-03-04 | IMATINIB | 02 | N | IMATINIB | 100254879 |
| 20215199 | 20081365 | null | null | Palliative (P) | 2019-07-18 | 2019-07-18 | Imatinib 400mg | N | N | IMATINIB | 101346060 |
| 20215200 | 20081366 | null | null | Curative (C) | 2017-03-17 | 2017-03-26 | Fluorouracil+Mitomycin+RT (Anal Ca) | 2 | Y | FLUOROURACIL + MITOMYCIN + RT | 101722575 |
| 20215202 | 20081367 | 1.79 | 90.1 | Palliative (P) | 2018-07-14 | 2018-08-11 | Trial Unspecified | 01 | N | TRIAL | 100829309 |
| 20215203 | 20081368 | 1.69 | 109.6 | Curative (C) | 2020-03-08 | 2020-04-09 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | TRIAL | 101820639 |
| 20215204 | 20081369 | 1.8 | 63.9 | Curative (C) | null | 2016-01-07 | null | null | N | TRIAL | 101359174 |
| 20215205 | 20081370 | 1.49 | 51.6 | Curative (C) | 2016-01-27 | 2016-02-27 | FLUOROURACIL + MITOMYCIN + RT | N | Y | FLUOROURACIL + MITOMYCIN + RT | 101605789 |
| 20215206 | 20081371 | 1.61 | 83.25 | Curative (C) | 2016-07-24 | 2016-07-24 | FLUOROURACIL + MITOMYCIN + RT | N | Y | FLUOROURACIL + MITOMYCIN + RT | 100066797 |
| 20215208 | 20081372 | 1.78 | null | Curative (C) | 2017-03-26 | 2017-04-16 | FLUOROURACIL + MITOMYCIN + RT | N | N | FLUOROURACIL + MITOMYCIN + RT | 100866945 |
| 20215209 | 20081373 | 1.51 | 72.65 | Curative (C) | 2017-05-15 | 2017-06-06 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | Y | FLUOROURACIL + MITOMYCIN + RT | 100151323 |
| 20215210 | 20081374 | 1.57 | 63.8 | Curative (C) | 2018-11-27 | 2018-12-26 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | Y | FLUOROURACIL + MITOMYCIN + RT | 101350211 |
| 20215211 | 20081375 | null | null | null | 2020-03-09 | 2020-03-21 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | null | LANREOTIDE | 100797482 |
| 20215212 | 20081376 | null | 102 | 03 | 2019-08-24 | 2019-08-25 | LANREOTIDE | 02 | N | LANREOTIDE | 101337613 |
| 20215214 | 20081377 | 1.53 | 89 | Palliative (P) | 2018-04-08 | 2018-05-04 | GO2 TRIAL | Y | N | TRIAL | 100926598 |
| 20215216 | 20081378 | 1.51 | 88 | Palliative (P) | 2017-10-27 | 2017-10-27 | Cape+Cisplatin+Trastuzumab Load | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100665266 |
| 20215217 | 20081379 | 1.62 | 79.05 | Palliative (P) | 2018-08-02 | 2018-08-03 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | IMATINIB | 101077415 |
| 20215219 | 20081380 | 1.81 | 78 | Curative (C) | 2018-11-22 | 2018-12-03 | FLUOROURACIL + MITOMYCIN + RT | 02 | Y | FLUOROURACIL + MITOMYCIN + RT | 101426116 |
| 20215221 | 20081381 | 1.78 | 93.8 | Palliative (P) | 2016-03-27 | 2016-04-07 | Cape+Cisplatin+Trastuzumab Main | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101153027 |
| 20215222 | 20081382 | 1.69 | 110.8 | null | 2018-03-18 | 2018-04-10 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | null | LANREOTIDE | 101064900 |
| 20215223 | 20081383 | 1.75 | 68.3 | Palliative (P) | 2018-07-20 | 2018-07-27 | Cape+Cisplatin+Trastuzumab Load | 02 | N | TRIAL | 100153549 |
| 20215225 | 20081385 | 1.6 | 64 | Palliative (P) | 2016-06-08 | 2016-06-08 | Cape+Cisplatin+Trastuzumab Load | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101251188 |
| 20215226 | 20081386 | 1.6 | 55.4 | Palliative (P) | 2019-12-23 | 2020-01-17 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101063592 |
| 20215228 | 20081387 | 1.62 | 47.8 | Palliative (P) | 2018-07-01 | 2018-07-09 | Cape+Cisplatin+Trastuzumab Load | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100279151 |
| 20215229 | 20081388 | 1.67 | 88.5 | Not known (9) | 2019-09-07 | 2019-09-07 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | Y | FLUOROURACIL + MITOMYCIN + RT | 100418435 |
| 20215231 | 20081389 | 1.75 | 81.8 | Curative (C) | 2018-09-08 | 2018-09-08 | Cape+Cisplatin+Trastuzumab Load | 02 | N | FLUOROURACIL + MITOMYCIN + RT | 101591861 |
| 20215232 | 20081390 | 1.8 | null | Curative (C) | 2017-05-23 | 2017-06-14 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | N | FLUOROURACIL + MITOMYCIN + RT | 101160496 |
| 20215233 | 20081391 | null | 0 | 03 | 2017-11-16 | 2017-11-17 | LANREOTIDE | N | N | LANREOTIDE | 101700862 |
| 20215234 | 20081392 | 1.8 | null | Palliative (P) | 2019-05-07 | 2019-05-18 | Trial Unspecified | N | N | TRIAL | 100681627 |
| 20215235 | 20081393 | null | null | null | 2019-09-08 | 2019-09-22 | Cape+Cisplatin+Trastuzumab Load | 02 | N | LANREOTIDE | 100631339 |
| 20215238 | 20081395 | 1.8 | 0 | Palliative (P) | 2019-09-07 | 2019-09-12 | Cape+Cisplatin+Trastuzumab Load | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101305267 |
| 20215240 | 20081397 | 1.7 | 64 | null | 2020-01-16 | 2020-01-16 | IMATINIB | 02 | null | IMATINIB | 101090266 |
| 20215241 | 20081398 | 1.58 | 56 | Palliative (P) | 2019-10-20 | 2019-10-20 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101564425 |
| 20215242 | 20081399 | 1.62 | 58.3 | Palliative (P) | 2016-04-28 | 2016-05-26 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100325596 |
| 20215243 | 20081400 | 1.76 | 69.8 | Curative (C) | 2019-06-03 | 2019-06-11 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | Y | FLUOROURACIL + MITOMYCIN + RT | 101449041 |
| 20215244 | 20081401 | 1.62 | 59.9 | Curative (C) | 2017-06-18 | 2017-07-06 | FLUOROURACIL + MITOMYCIN + RT | N | Y | FLUOROURACIL + MITOMYCIN + RT | 101767037 |
| 20215245 | 20081402 | 1.65 | 59 | Curative (C) | null | 2019-07-13 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | N | FLUOROURACIL + MITOMYCIN + RT | 100354314 |
| 20215248 | 20081403 | null | 98.2 | null | 2018-12-23 | 2019-02-03 | LANREOTIDE | 02 | N | LANREOTIDE | 100607845 |
| 20215249 | 20081404 | null | 92 | Palliative (P) | 2018-05-24 | 2018-05-24 | LANREOTIDE | 99 | N | LANREOTIDE | 100785420 |
| 20215251 | 20081405 | 0 | 79.8 | null | 2016-09-12 | 2016-10-01 | IMATINIB | N | null | IMATINIB | 100406006 |
| 20215254 | 20081407 | 1.72 | 88.5 | Palliative (P) | null | 2018-07-09 | Trial Unspecified | Y | N | TRIAL | 101474901 |
| 20215255 | 20081408 | 1.74 | 83 | Curative (C) | 2019-05-24 | 2019-06-06 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | null | FLUOROURACIL + MITOMYCIN + RT | 100665167 |
| 20215257 | 20081409 | 0 | 71.7 | Palliative (P) | 2017-03-22 | 2017-03-29 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | IMATINIB | 101140880 |